Insufficient scRNA-seq data for expression of MFSD2B at single-cell level.
Insufficient scRNA-seq data for expression of MFSD2B at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 99% | 66.65 | 573 / 578 | 7% | 0.10 | 80 / 1155 |
uterus | 91% | 21.91 | 155 / 170 | 10% | 0.16 | 46 / 459 |
ureter | 0% | 0 | 0 / 0 | 100% | 1.92 | 1 / 1 |
spleen | 98% | 74.44 | 237 / 241 | 0% | 0 | 0 / 0 |
bladder | 86% | 16.05 | 18 / 21 | 8% | 0.13 | 42 / 504 |
prostate | 89% | 20.58 | 219 / 245 | 0% | 0.00 | 1 / 502 |
peripheral blood | 86% | 285.51 | 802 / 929 | 0% | 0 | 0 / 0 |
skin | 75% | 16.99 | 1351 / 1809 | 8% | 0.14 | 39 / 472 |
intestine | 71% | 10.39 | 688 / 966 | 10% | 0.18 | 53 / 527 |
brain | 78% | 25.88 | 2069 / 2642 | 1% | 0.01 | 5 / 705 |
esophagus | 69% | 11.30 | 1003 / 1445 | 7% | 0.09 | 12 / 183 |
adipose | 68% | 9.82 | 823 / 1204 | 0% | 0 | 0 / 0 |
liver | 58% | 9.41 | 132 / 226 | 9% | 0.23 | 38 / 406 |
breast | 63% | 8.49 | 291 / 459 | 2% | 0.03 | 24 / 1118 |
thymus | 59% | 7.45 | 384 / 653 | 2% | 0.03 | 11 / 605 |
blood vessel | 59% | 7.73 | 789 / 1335 | 0% | 0 | 0 / 0 |
ovary | 57% | 7.89 | 102 / 180 | 2% | 0.03 | 8 / 430 |
stomach | 50% | 6.58 | 181 / 359 | 7% | 0.10 | 19 / 286 |
lymph node | 0% | 0 | 0 / 0 | 55% | 1.09 | 16 / 29 |
kidney | 54% | 7.26 | 48 / 89 | 1% | 0.03 | 10 / 901 |
muscle | 48% | 5.39 | 386 / 803 | 0% | 0 | 0 / 0 |
heart | 44% | 5.46 | 382 / 861 | 0% | 0 | 0 / 0 |
adrenal gland | 33% | 3.44 | 86 / 258 | 1% | 0.03 | 3 / 230 |
pancreas | 15% | 1.47 | 49 / 328 | 5% | 0.08 | 9 / 178 |
tonsil | 0% | 0 | 0 / 0 | 2% | 0.03 | 1 / 45 |
eye | 0% | 0 | 0 / 0 | 1% | 0.01 | 1 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0030148 | Biological process | sphingolipid biosynthetic process |
GO_0008643 | Biological process | carbohydrate transport |
GO_0003376 | Biological process | sphingosine-1-phosphate receptor signaling pathway |
GO_1901731 | Biological process | positive regulation of platelet aggregation |
GO_0055085 | Biological process | transmembrane transport |
GO_0006869 | Biological process | lipid transport |
GO_0005886 | Cellular component | plasma membrane |
GO_0015293 | Molecular function | symporter activity |
GO_0046624 | Molecular function | sphingolipid transporter activity |
Gene name | MFSD2B |
Protein name | MFSD2 lysolipid transporter B, sphingolipid Sphingosine-1-phosphate transporter MFSD2B (Major facilitator superfamily domain-containing protein 2B) (hMfsd2b) |
Synonyms | |
Description | FUNCTION: Lipid transporter that specifically mediates export of sphingosine-1-phosphate in red blood cells and platelets . Sphingosine-1-phosphate is a signaling sphingolipid and its export from red blood cells into in the plasma is required for red blood cell morphology (By similarity). Sphingosine-1-phosphate export from platelets is required for platelet aggregation and thrombus formation (By similarity). Mediates the export of different sphingosine-1-phosphate (S1P) species, including S1P(d18:0) (sphinganine 1-phosphate), S1P (d18:1) (sphing-4-enine 1-phosphate) and S1P (d18:2) (sphinga-4E,14Z-dienine-1-phosphate) (Probable). Release of sphingosine-1-phosphate is facilitated by a proton gradient (By similarity). In contrast, cations, such as sodium, are not required to drive sphingosine-1-phosphate transport (Probable). In addition to export, also able to mediate S1P import (By similarity). Does not transport lysophosphatidylcholine (LPC) (Probable). . |
Accessions | H7BZN4 ENST00000669179.1 A6NFX1 A0A2I3JL00 A0A590UK14 ENST00000453731.1 ENST00000338315.6 ENST00000406420.7 |